World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

Abstract

CADASIL AND CARASIL: A MUTATED HEREDITARY LEUKOENCEPHALOPATHY – NEW FINDINGS

*Abinaya Arulappan, Venkateswaramurthy Nallasamy

ABSTRACT

CADASIL - Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leuko- encephalopathy is a genetic disorder this is due to the mutation within the NOTCH3 gene.[1] NOTCH3 gene provides formation for producing the notch3 receptor proteins this is concerned within the functioning and survival of vascular smooth muscle groups. Mutation on this gene produces abnormal production of NOTCH3 receptor proteins that impairs the characteristic of the small blood vessels.[2] Clinical manifestations contain stroke, TIAs, migraine with aura, hypo densities of the white matter within the subcortical region, incidence of seizure and psychiatric disturbances and cognitive disturbances. There isn't any particular remedy for this situation it could only be treated symptomatically.[3] CADASIL is responsible for recurrent ischemic stroke during mid-adulthood and can lead to severe motor disability and cognitive decline.[4-5]

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR